Granpool Innovative Investments
VC Fund
Arnhem, The Netherlands
Granpool Innovative Investments is a VC fund in Arnhem focused on Software and Information Technology. It acquires significant minority stakes in innovative companies without any industrial or geographical focus. Based on this approach, a global network of ventures has been created since 2015. Currently, Granpool is interested in fintech, finance, mobility, healthcare, robotics, IT and VR related developing companies which have a presence in Asia,Europe, North and South America.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Granpool Innovative Investments invests in
Stages Granpool Innovative Investments invests in
Countries Granpool Innovative Investments invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Pre-Seed
- $821k–$1M
- Series A
- $9M–$10M
Investment Focus
Industry
- Software 5 (25%)
- Information Technology 3 (15%)
- Robotics 2 (10%)
- Biotechnology 2 (10%)
- Industrial Automation 2 (10%)
Stage
- Seed 4 (20%)
- Pre-Seed 3 (15%)
- Series A 3 (15%)
- Funding Round 3 (15%)
- Series B 2 (10%)
Country
- United States 3 (15%)
- Hungary 2 (10%)
- Canada 1 (5%)
- Denmark 1 (5%)
- United Kingdom 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Miklos Kobor
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Paul de Ruijter
Managing Director
|
Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Eagle Genomics is a enterprise software solutions company whose products enable the management, orchestration and exploitation of genomics and other life sciences data. They help Life Science companies get the maximum value from their R&D data and they are delivering the information architecture for the genomics era. Their suite of softwareproducts radically reduces cost and time to complete research, enabling drastic productivity improvements.Their architecture translates data sets into data assets, redefining the current paradigm in the industry, enabling the objective measurement of the value of digital assets and providing clarity on “return on information”. Their mix of expertise in biology, bioinformatics, data science and enterprise-class software engineering is unique in the field and has been applied over the last decade to solve their customers’ challenges in areas as diverse as drug development, personal hygiene and plant breeding.With global customers in the pharmaceuticals, fast moving consumer goods and agri-tech industries they understand the common challenges facing these industries in the handling of ever growing of data and information resources. Eagle Genomics is at the forefront in addressing the challenges, risks, and opportunities in delivering the enterprise information architecture for the genomics era. | $3.6M / Venture - Series Unknown / Sep 27, 2023 | ||
| Eagle Genomics is a enterprise software solutions company whose products enable the management, orchestration and exploitation of genomics and other life sciences data. They help Life Science companies get the maximum value from their R&D data and they are delivering the information architecture for the genomics era. Their suite of softwareproducts radically reduces cost and time to complete research, enabling drastic productivity improvements.Their architecture translates data sets into data assets, redefining the current paradigm in the industry, enabling the objective measurement of the value of digital assets and providing clarity on “return on information”. Their mix of expertise in biology, bioinformatics, data science and enterprise-class software engineering is unique in the field and has been applied over the last decade to solve their customers’ challenges in areas as diverse as drug development, personal hygiene and plant breeding.With global customers in the pharmaceuticals, fast moving consumer goods and agri-tech industries they understand the common challenges facing these industries in the handling of ever growing of data and information resources. Eagle Genomics is at the forefront in addressing the challenges, risks, and opportunities in delivering the enterprise information architecture for the genomics era. | Oct 31, 2022 | ||
| Eagle Genomics is a enterprise software solutions company whose products enable the management, orchestration and exploitation of genomics and other life sciences data. They help Life Science companies get the maximum value from their R&D data and they are delivering the information architecture for the genomics era. Their suite of softwareproducts radically reduces cost and time to complete research, enabling drastic productivity improvements.Their architecture translates data sets into data assets, redefining the current paradigm in the industry, enabling the objective measurement of the value of digital assets and providing clarity on “return on information”. Their mix of expertise in biology, bioinformatics, data science and enterprise-class software engineering is unique in the field and has been applied over the last decade to solve their customers’ challenges in areas as diverse as drug development, personal hygiene and plant breeding.With global customers in the pharmaceuticals, fast moving consumer goods and agri-tech industries they understand the common challenges facing these industries in the handling of ever growing of data and information resources. Eagle Genomics is at the forefront in addressing the challenges, risks, and opportunities in delivering the enterprise information architecture for the genomics era. | $19.8M / Series B / Oct 31, 2022 | ||
| Creating an API-driven marketplace for geo-triggered coverages for the embedded insurance industry. | $821K / Pre-Seed / Aug 01, 2022 | ||
| Our mission is to help organizations prevent security breaches by establishing a prudent and automated auditing process to discover employees with high digital risk factor. | $1M / Pre-Seed / Jun 16, 2022 | ||
| Putting leading scientific data into context, to enable others to respond to climate change’s dynamism and act on solutions with confidence. | Pre-Seed / Sep 13, 2021 | ||
| Our mission is to help organizations prevent security breaches by establishing a prudent and automated auditing process to discover employees with high digital risk factor. | Pre-Seed / Jul 08, 2021 | ||
| Eagle Genomics is a enterprise software solutions company whose products enable the management, orchestration and exploitation of genomics and other life sciences data. They help Life Science companies get the maximum value from their R&D data and they are delivering the information architecture for the genomics era. Their suite of softwareproducts radically reduces cost and time to complete research, enabling drastic productivity improvements.Their architecture translates data sets into data assets, redefining the current paradigm in the industry, enabling the objective measurement of the value of digital assets and providing clarity on “return on information”. Their mix of expertise in biology, bioinformatics, data science and enterprise-class software engineering is unique in the field and has been applied over the last decade to solve their customers’ challenges in areas as diverse as drug development, personal hygiene and plant breeding.With global customers in the pharmaceuticals, fast moving consumer goods and agri-tech industries they understand the common challenges facing these industries in the handling of ever growing of data and information resources. Eagle Genomics is at the forefront in addressing the challenges, risks, and opportunities in delivering the enterprise information architecture for the genomics era. | $9M / Series A / Oct 26, 2020 | ||
| 2D meetings are all over the world. We are stuck with the small windows of video conferencing. The lessons of COVID are accelerating ’new work’ practices that broadly encourage minimized travel and remote collaboration.It's time to deliver a sense of presence and connection for people. We have the solution now. The most realisticholographic communication on the planet.MATSUKO is a B2B software company that revolutionizes the way organizations and people communicate remotely today. It brings people closer and improves collaboration. It creates the holographic communication that fills in the missing element in video conferences, the essence of communication, their presence. It delivers the most realistic experience of being physically anywhere while zeroing down the environmental impact by just using a single camera and a pair of mixed reality glasses. | $2.7M / Seed / Nov 01, 2019 | ||
| REscan is digitizing the physical world starting with large commercial real estate portfolios, making them remotely viewable, analyzable, editable, and XR ready. | Venture - Series Unknown / Sep 23, 2019 | ||
| See all 20 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Granpool Innovative Investments invest in?
Granpool Innovative Investments invests primarily in Software, Information Technology and Robotics startups, most often at Seed and Pre-Seed stage. Most of the 20 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Granpool Innovative Investments's check size?
Granpool Innovative Investments typically joins rounds of $821k–$1M at Pre-Seed and $9M–$10M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Granpool Innovative Investments participates in.
How do I contact Granpool Innovative Investments?
Public channels for Granpool Innovative Investments include X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Granpool Innovative Investments?
The team at Granpool Innovative Investments includes Miklos Kobor (Managing Director) and Paul de Ruijter (Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
